News & Updates
Stay updated on the latest exhibition news, announcements, and biomanufacturing industry trends
Upgrade to Forum Pass for only 0! Yi Mao Bio-Manufacturing Conference: Full Schedule Released
Read moreLife from Biology! Join 2026 Yimao Biomanufacturing Summit "Creation Festival" to witness the power of intelligent manufacturing.
Read moreLeading the Bio-based Frontier: Sugar Energy Tech's Core Management Team Takes Center Stage at 2026 Ecomobio Manufacturing Conference
Read moreLed by professors from South China University of Technology, East China University of Science and Technology, and Jiangnan University: Synthetic biology reshaping beauty ingredients and unlocking the full spectrum of internal调理 and external care.
Read morePumi Bio partners with Xinhangyuan to bring biomass alcohol-based SAF production costs close to 10,000 yuan per ton.
Read more[Official Announcement] Full Schedule for 2026 EMT Bio-Manufacturing Conference Revealed! Connecting the Industry, Innovating the Future
Read moreGet a first look at top-tier biomanufacturing projects! Registration is now open—connect directly with leading investors.
Read moreConnect with top enterprises and $10B+ capital! Early-bird registration for the Yimao Bio-Manufacturing Conference is now live.
2026 (2nd) Yimao Bio-Manufacturing Industry Conference & Exhibition (Summer Edition) will be held in Shanghai from 8 to 28. The event will bring together over 2000 attendees, 100 speakers, and 20 premium exhibitors. Through four core modules—Conference, Exhibition, Meetings, and Activities—it focuses on "scientific breakthroughs at the foundational level + cross-industry commercialization," covering key sectors such as medical aesthetics, bio-based materials, green chemistry, food, agriculture, and AI-enabled solutions. By deeply connecting top-tier researchers, industry leaders, innovative SMEs, investors, and upstream/downstream supply chains, this event establishes a benchmark for the entire bio-manufacturing value chain.
Read moreLast day to claim your 0 yuan forum ticket! Led by professors from Wuhan University, Zhejiang University, and East China University of Science and Technology: AI drives disruptive innovation while enabling scalable production.
The biomanufacturing industry has long faced a stark reality: many breakthroughs in the lab rarely make it to production.
Read moreIs AI making enzyme engineering as simple as coding? China's first "Omics+" Enzyme Agent upgrades!
Recently, AI-driven biomanufacturing company Xinbeilai Biologics announced a major upgrade to its core computational platform, Xuanzhu SynGears. The company has successfully launched SynGears Omni, China's first "Omics+" enzyme agent.
Read moreJinbo Bio's founder Yang Xia steps down as General Manager; former Adicon CEO Gao Song takes over.
Recently, BSE-listed leader in recombinant collagen, Jinbo Biology, announced a major executive leadership change. Founder and Chairman Yang Xia will step down as General Manager, with Gao Song, former CEO of Aidi Kang Holding and nearly 30 years of experience across the full pharmaceutical and healthcare value chain, appointed as the new General Manager. The appointment is effective immediately and will serve until the current term of the Board of Directors concludes.
Read more[First Look at the Agenda] Chief Scientist from the Chinese Academy of Agricultural Sciences Joins Forces! Executives from DBN, Mu'en, Liangping, and Momi Unite to End the "Sample Dilemma" in Alternative Proteins
Currently, China faces high external dependence for protein supply and increasingly acute shortages in feed protein resources. Traditional farming and breeding models are resource-intensive and generate high carbon emissions, making them ill-suited to meet rising protein demand.
Read moreMGI出资5200万元，参与设立海洋生物制造专项基金
On 6 23, MGI Group issued an official announcement stating that the company intends to subscribe to 5200 yuan in capital using its own funds. Together with partners including Haida Win-Win (Shenzhen) Equity Investment Fund Management Co., Ltd., MGI will establish a specialized venture capital fund for marine biomanufacturing. This initiative aims to comprehensively expand into marine microbiology, synthetic biology, and deep-sea equipment sectors, leveraging capital to empower core technologies and drive the development of new quality productive forces in the ocean industry.
Read moreAlternative Protein Market Surges: Cultured Meat Nears Your Table
Have you ever imagined that the steak or pork chop you eat one day won't come from a farm, but from a bioreactor in a lab?
Read moreCan AI reduce strain cultivation from 1-2 years to just days? Huaxi Bio's Zhao Yan: The rules of the game are changing
During the recently concluded 2026 APEC Business Advisory Council China Forum, Hua-Xi Bio Chairman Zhao Yan drew widespread attention with her statement: "Traditionally, cultivating microbial strains typically takes one to two years. With AI-driven simulation, we can now achieve results in just a few months—and as quickly as mere days."
Read moreFirst batch of AI+BioManufacturing certified by MIIT! Prof. Hu Qiannan from Wuhan University confirmed to attend Yimao BioManufacturing Conference!
As artificial intelligence accelerates and converges deeply with synthetic biology, AI-driven biomanufacturing has become a strategic pinnacle in global tech competition. From multimodal knowledge graphs to multi-agent systems, from enzyme-mining foundation models to de novo pathway design—AI is reshaping the core innovation logic of biomanufacturing at an unprecedented pace, driving the industry from an "experience-driven" model to a new paradigm of "data-driven + intelligence-driven."
Read moreTrillion-yuan state-owned enterprise Guangming Group partners with Guobang Pharmaceutical to invest in bio-manufacturing!
On 6/15, the state-owned enterprise Guangming Food Group, with assets of over 100 billion yuan, and Guobang Pharmaceutical, a leading listed company in active pharmaceutical ingredients (APIs), officially signed a fund investment agreement to establish a strategic partnership.
Read moreCut costs by 97%? "Physical AI" enters biomanufacturing: Gao Te Jia leads Jin Du Sheng Ke's Series A round
New breakthroughs are emerging in the AI for Science space. Recently, Shenzhen Jindu Biomedical Technology Co., Ltd. (Jindu Bio) announced it has raised nearly 100 million RMB in its Series A funding round, led by Gotai Investment.
Read moreCATL Enters Biomanufacturing? Carbon Genesis Completes Series A Funding
Recently, Shanghai Tan Sheng Wan Wu Technology Co., Ltd. announced the completion of its A-round financing. The round was jointly led by Yellow River Delta Investment, GaoRong Capital, and Boyuan Capital, with new investors including CATL, Sungrow Power Supply, and Yifeng Capital.
Read more